CORONAVIRUS: CHINESE SCIENTISTS DESTROYED PROOF OF VIRUS IN DECEMBER

Philip Sherwell, Bangkok
The Sunday Times
March 01 2020

Chinese laboratories identified a mystery virus as a highly infectious new pathogen by late December last year, but they were ordered to stop tests, destroy samples and suppress the news, a Chinese media outlet has revealed.

A regional health official in Wuhan, centre of the outbreak, demanded the destruction of the lab samples that established the cause of unexplained viral pneumonia on January 1. China did not acknowledge there was human-to-human transmission until more than three weeks later.

The detailed revelations by Caixin Global, a respected independent publication, provide the clearest evidence yet of the scale of the cover-up in the crucial early weeks when the opportunity was lost to control the outbreak.

Censors have been rapidly deleting the report from the Chinese internet.

Caixin reported that several genomics companies sequenced the coronavirus by December 27 from samples from patients who had fallen sick in Wuhan.

There was a striking similarity between the new virus and the Sars (severe acute respiratory syndrome) coronavirus that killed nearly 800 people in 2002-3. But the news was shared with only a small group of medics and party officials.

The laboratory findings were relayed to officials in Beijing at the Centre for Disease Control (CDC). The information should have alerted national health chiefs to a looming crisis, but on January 3, the National Health Commission, China’s top medical authority, issued its own gagging orders. Laboratories were told not to release any information and to hand over or destroy the samples.

When a CDC team was sent to Wuhan on January 8, it was deliberately not informed that medical staff had already been infected by patients — a clear confirmation that the disease was contagious.

The cover-up was led by officials in Wuhan as provincial party chiefs prepared to gather for an annual meeting. The city then pressed ahead with a pot-luck dinner for 40,000 families to celebrate the lunar new year.

Only on January 20 was it made public, in an interview with Zhong Nanshan, a respiratory health expert who led the fight against Sars, that the disease was spreading between humans.

Wuhan,with a population of 11 million, was put into lockdown on January 23 as the communist authorities finally tried to control the spread of the disease.

Moses,

Very interesting information that you present in your post. Thank you so much. And since everything is possible, I agree with you that the covid-19 pandemic could be an extension on earth of the war in heaven.

But I also think that the current covid-19 situation can be beneficial to man because it provides him the opportunity to experience ONENESS, or the realization that everything is connected, that separation does not exists.

In addition, the current pandemic can be beneficial to man because it offers him a way out of the reincarnation cycle on Earth.

When man’s ONENESS with God is deeply and fully experienced both at the soul and body cells levels. And if this experience is coupled with the fully integrated belief that man is made at the image of God.

Then, man can and will come to the realization that he is God too.

And at that point, the objective of the Earth Experiment is achieved. And man can stop incarnating on Earth.

The objective of the Earth Experiment is for man to voluntarily forget his divine nature at the time of birth; then through his incarnation(s) on earth, work his way back to the realization that he is a Sovereign Immortal Being, that he is God.

A COVID-19 VACCINE HAS PASSED ITS FIRST HUMAN TRIAL. BUT IS IT THE FRONTRUNNER?

This is a well written, easy to read paper. Highly recommended.

This is a very interesting article published by National Geographic, about Moderna Therapeutics’ covid-19 vaccine that has just successfully completed phase 1 clinical trial where it proved to be safe in healthy adult humans, and also triggered the release of antibodies against the virus in study participants.

Starting next week, this vaccine will enter phase 2 clinical trial with 600 humans to see if the antibodies developed against covid-19 can neutralize this virus.

This is important because Moderna’s covid-19 vaccine is a mRNA vaccine -- and the first one in the new class of DNA and mRNA vaccines – that is proven to be safe in humans. So far, DNA and mRNA vaccines have worked only in animals. The big advantage with DNA and mRNA vaccines is that they can be produced much faster and cheaper than traditional vaccines.

National Geographic did a good job with this article because it is written in plain English for all readers. And graphics are easy to understand. In addition, this article gives the history of DNA and mRNA vaccines, and explains how they are different from traditional vaccines.

Click below to get the article:

https://www.nationalgeographic.com/science/2020/05/coronavirus-vaccine-passes-first-human-trial-but-is-it-frontrunner-cvd/

The structure of covid-19 virus (or SARS cov-2):

Rashid,

Thank you for your post.

Most of the views that you are expressing go beyond the scope and scale of Farsight RV session, or the ensuing discussion in this thread.

So, it would be pointless to address the 4 points that you are making.

Nevertheless, thank you for expressing your thoughts and viewpoints here.

A Short Video on some of the Known Symptoms of Covid-19

I came across two transcripts of Project Camelot interviews conducted in 2006 and 2007 with Arthur Neumann, aka Henry Deacon, a Lawrence Livermore Lab physicist.

Lot of interesting info, and some might pertain to our time. For example, in both the 2006 and 2007 documents Henry Deacon talks about “stealth pathogens have been covertly deployed with the intention of reducing the world's population… to a manageable 500 million “.

And, in the 2007 interview, he mentions that “vitamin D3 (5000 IU per day) provides excellent cheap insurance against viral epidemics, whether natural or engineered”.

Very interesting!

Here is the link for the transcripts of the 2006 and 2007 interviews. I double-checked it and it works.

http://projectcamelot.org/lang/en/An_Interview_with_Henry_Deacon_a_Livermore_Physicist_(Sep_2006-Dec_2007).pdf

HYDROXYCHLOROQUINE STUDY

If you are taking (or thinking about taking) the antimalarial drug chloroquine or its analog hydroxychloroquine because you think that it would protect you against covid-19, please read the summary of the following study published in The Lancet issue of May 22, 2020.

HYDROXYCHLOROQUINE OR CHLOROQUINE WITH OR WITHOUT A MACROLIDE FOR TREATMENT OF COVID-19: A MULTINATIONAL REGISTRY ANALYSIS.

Prof Mandeep R Mehra, MD , Sapan S Desai, MD, Prof Frank Ruschitzka, MD, Amit N Patel, MD

The Lancet, May 22, 2020. https://doi.org/10.1016/S0140-6736(20)31180-6

SUMMARY

Background

Hydroxychloroquine or chloroquine, often in combination with a second-generation macrolide, are being widely used for treatment of COVID-19, despite no conclusive evidence of their benefit. Although generally safe when used for approved indications such as autoimmune disease or malaria, the safety and benefit of these treatment regimens are poorly evaluated in COVID-19.

Methods

We did a multinational registry analysis of the use of hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19. The registry comprised data from 671 hospitals in six continents. We included patients hospitalised between Dec 20, 2019, and April 14, 2020, with a positive laboratory finding for SARS-CoV-2. Patients who received one of the treatments of interest within 48 h of diagnosis were included in one of four treatment groups (chloroquine alone, chloroquine with a macrolide, hydroxychloroquine alone, or hydroxychloroquine with a macrolide), and patients who received none of these treatments formed the control group. Patients for whom one of the treatments of interest was initiated more than 48 h after diagnosis or while they were on mechanical ventilation, as well as patients who received remdesivir, were excluded. The main outcomes of interest were in-hospital mortality and the occurrence of de-novo ventricular arrhythmias (non-sustained or sustained ventricular tachycardia or ventricular fibrillation).

Findings

96 032 patients (mean age 53·8 years, 46·3% women) with COVID-19 were hospitalised during the study period and met the inclusion criteria. Of these, 14 888 patients were in the treatment groups (1868 received chloroquine, 3783 received chloroquine with a macrolide, 3016 received hydroxychloroquine, and 6221 received hydroxychloroquine with a macrolide) and 81 144 patients were in the control group. 10 698 (11·1%) patients died in hospital. After controlling for multiple confounding factors (age, sex, race or ethnicity, body-mass index, underlying cardiovascular disease and its risk factors, diabetes, underlying lung disease, smoking, immunosuppressed condition, and baseline disease severity), when compared with mortality in the control group (9·3%), hydroxychloroquine (18·0%; hazard ratio 1·335, 95% CI 1·223–1·457), hydroxychloroquine with a macrolide (23·8%; 1·447, 1·368–1·531), chloroquine (16·4%; 1·365, 1·218–1·531), and chloroquine with a macrolide (22·2%; 1·368, 1·273–1·469) were each independently associated with an increased risk of in-hospital mortality. Compared with the control group (0·3%), hydroxychloroquine (6·1%; 2·369, 1·935–2·900), hydroxychloroquine with a macrolide (8·1%; 5·106, 4·106–5·983), chloroquine (4·3%; 3·561, 2·760–4·596), and chloroquine with a macrolide (6·5%; 4·011, 3·344–4·812) were independently associated with an increased risk of de-novo ventricular arrhythmia during hospitalisation.

Interpretation

We were unable to confirm a benefit of hydroxychloroquine or chloroquine, when used alone or with a macrolide, on in-hospital outcomes for COVID-19. Each of these drug regimens was associated with decreased in-hospital survival and an increased frequency of ventricular arrhythmias when used for treatment of COVID-19.

Funding

William Harvey Distinguished Chair in Advanced Cardiovascular Medicine at Brigham and Women's Hospital.

Why would they use a Macrolid? (The macrolides inhibit the growth of bacteria and are often prescribed to treat rather common bacterial infections). This is not a bacteria issue.

The reports I have read say HCQ is only effective for covid19 when used in conjunction with zinc.

Matt, good point!

Hydroxychloroquine and chloroquine are quinine derivatives. So, they are mainly used to treat malaria in tropical countries or wherever this disease is prevalent. And in those countries, they are INDICATED to be used with or without macrolides. They can also be used to treat autoimmune diseases and microbial infections.

So, without any type of medical guidance or reference on how to use these quinine products on covid-19 patients where they are not indicated, physicians in malaria infested countries simply applied their malaria experience with these products to attempt to treat covid-19 patients.

But the key point here is that this Lancet study is not a clinical trial. It is a multinational registry or chart review study. So, to a point it is a retrospective study.

And in this registry/chart review study, the data used are collected from the medical charts of covid-19 patients who were treated with hydroxychloroquine or chloroquine. Most of these patients live in tropical areas where macrolides can be used with the latter 2 products. That’s why macrolides are present in this study.

What is needed is a clinical trial specific to the use of quinine analogs on covid-19 patients. It would be nice because these are very cheap products. But with remdesivir around the corner, it’s going to be challenging to have a trial with hydroxychloroquine or chloroquine on covid-19 pts.

The Lancet is rotten and the study cited is irrelevant.
See this: https://www.naturalnews.com/2020-04-27-study-claims-hydroxychloroquine-doesnt-work-coronavirus-left-out-zinc.html

HOW CORONAVIRUS TESTS WORK

Click on the link

https://www.pbs.org/wgbh/nova/video/how-coronavirus-tests-work/

Spirituality and Wisdom in the Time of Corona from sister Chân Không, a Buddhist nun in Vietnam. In short, “We are One”.

This coronavirus mutation has taken over the world. Scientists are trying to understand why.
Sarah Kaplan, Joel Achenbach

Very interesting!

https://www.msn.com/en-us/news/technology/this-coronavirus-mutation-has-taken-over-the-world-scientists-are-trying-to-understand-why/ar-BB166pjJ

Earthfiles, July 1st 2020. Linda Moulton Howe’s Perspectices on Covid-19 and Other Topics...

Linda is someone who can discuss science and esoteric matters in an intelligent and convincing way.